Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Journal of Leukocyte Biology|August 3, 2026
The Pentose Phosphate Pathway in ImmunotherapyRachel D Loo, John BlazeckCurrent Opinion in Biomedical Engineering|October 21, 2024
Exploiting protein domain modularity to enable synthetic control of engineered cellsYusef Haikal, John BlazeckBiotechnology Journal|February 13, 2010
Systems metabolic engineering: genome-scale models and beyondJohn Blazeck, Hal AlperJournal of Biological Engineering|December 27, 2022
High throughput mutagenesis and screening for yeast engineeringKendreze Holland, John BlazeckMetabolic Engineering|November 3, 2024
Applying metabolic control strategies to engineered T cell cancer therapiesAndrea C Fox, John BlazeckTrends in Biotechnology|October 10, 2021
Protein engineering: a driving force toward synthetic immunologyJohn R Cox, John BlazeckBiotechnology Journal|August 5, 2021
Advances in promoter engineering: Novel applications and predefined transcriptional controlAndrew P Cazier, John BlazeckBiotechnology Journal|August 15, 2012
Promoter engineering: recent advances in controlling transcription at the most fundamental levelJohn Blazeck, Hal S AlperJournal of Biotechnology|February 14, 2012
Evolution of an alkane-inducible biosensor for increased responsiveness to short-chain alkanesBen Reed, John Blazeck, Hal AlperJournal for Immunotherapy of Cancer|October 20, 2021
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forwardMaria Rain Jennings, David Munn, John BlazeckPageof 4